Atlas Venture Life Science Advisors, LLC Q3 2024 Filing
Filed November 13, 2024
Portfolio Value
$1.1T
Holdings
14
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DYNDyne Therapeutics, Inc. | 8,020,136 | $288.1B | 26.71% | |
| 2 | KYMRKymera Therapeutics, Inc. | 4,896,462 | $231.7B | 21.48% | |
| 3 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $147.8B | 13.70% | |
| 4 | IRONDisc Medicine, Inc. | 2,509,456 | $123.3B | 11.43% | |
| 5 | QTTBQ32 Bio, Inc. | 2,092,106 | $93.3B | 8.65% | |
| 6 | DAWNDay One Biopharmaceuticals, Inc. | 6,430,257 | $89.6B | 8.30% | |
| 7 | KRROKorro Bio, Inc. | 1,137,149 | $38.0B | 3.52% | |
| 8 | GBIOGBXGeneration Bio, Co. | 8,279,484 | $20.5B | 1.90% | |
| 9 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $19.8B | 1.84% | |
| 10 | TECXTectonic Therapeutics, Inc. | 378,447 | $11.5B | 1.06% | |
| 11 | —Ikena Oncology, Inc. | 5,018,178 | $8.7B | 0.80% | |
| 12 | AVTEAerovate Therapeutics, Inc. | 1,799,232 | $3.8B | 0.35% | |
| 13 | DNTHDianthus Therapeutics, Inc. | 76,979 | $2.1B | 0.20% | |
| 14 | SPROSpero Therapeutics, Inc. | 402,885 | $539.9M | 0.05% |